Skip to main content

S92.344S vs S92.345S

S92.344S (Nondisplaced fracture of fourth metatarsal bone, right foot, sequela) compared with S92.345S (Nondisplaced fracture of fourth metatarsal bone, left foot, sequela), from the official CMS tabular data. S92.344S and S92.345S code the same condition on opposite sides. MedCoder-derived

Relationship

Review

Laterality relationship

S92.344S
Right
Nondisplaced fracture of fourth metatarsal bone, right foot, sequela
S92.345S
Left
Nondisplaced fracture of fourth metatarsal bone, left foot, sequela

Same condition; these differ only in which side is documented.

These codes share a category and title and differ only in the side affected. The documentation decides which applies, and a bilateral code is reported only where the code set provides one.

Source: ICD-10-CM tabular list (laterality variant derived from the code title)

Can these codes be reported together?

Same condition, opposite side. S92.344S and S92.345S name the same condition on opposite sides of the body.

Same category and title, differing only in which side is affected — the documentation decides which one applies, and a bilateral code is reported only where the code set provides one.

Side by side

S92.344SNondisplaced fracture of fourth metatarsal bone, right foot, sequelaS92.345SNondisplaced fracture of fourth metatarsal bone, left foot, sequela
Billing statusBillableBillable
ClassificationS00-T88 — Injury, poisoning and certain other consequences of external causesS00-T88 — Injury, poisoning and certain other consequences of external causes
DefinitionNondisplaced fracture of fourth metatarsal bone, right foot, sequela is a billable ICD-10-CM diagnosis code (S92.344S).Nondisplaced fracture of fourth metatarsal bone, left foot, sequela is a billable ICD-10-CM diagnosis code (S92.345S).
7th characterThe appropriate 7th character is to be added to each code from category S92The appropriate 7th character is to be added to each code from category S92

Derived from the official CMS ICD-10-CM tabular data (FY2026). Not billing advice; verify sequencing rules for the encounter. All data sources